2025) Unusual, acquired, or rapidly changing pigmentation where malignancy cannot be excluded - Evaluate promptly
During GLP-1 therapy, maintain regular thyroid function testing: baseline, 6 weeks, 12 weeks, and then every 3 months for the first year
Food Funct 11(6):56645673 Lambert JE, Ramos-Roman MA, Browning JD, Parks EJ (2014) Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease
Dehydration-related renal impairment is a risk, particularly in patients with pre-existing kidney disease
A competitive brand whose exclusivity you had modeled as ending in 2025 that successfully obtained an extended pediatric exclusivity period is a meaningfully different formulary competitor than one facing near-term generic entry
Evidence quality varies across peptide research, and neither blend is proven to deliver universal anti-aging or guaranteed recovery results outcomes depend on the research context